Occidental Asset Management’s Mateon Therapeutics MATN Stock Holding History
Bought
Maintained
Sold
Other funds holding MATN
Occidental Asset Management's MATN Position: Q4 2016 in Review
Occidental Asset Management sold out of Mateon Therapeutics (MATN) in Q4 2016, closing a stake of 10,000 shares — an estimated $6K sold.
Occidental Asset Management first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $7K in Q2 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.
- Occidental Asset Management reported no remaining Mateon Therapeutics position as of Q4 2016 after selling out during the quarter.
- Occidental Asset Management sold 10,000 Mateon Therapeutics shares in Q4 2016, an estimated $6K.
- Occidental Asset Management first reported a position in Mateon Therapeutics in Q2 2016 and held it in 2 quarters.
- Occidental Asset Management's Mateon Therapeutics position peaked at $7K in Q2 2016.
- 1 fund tracked by Wall St. Rank held Mateon Therapeutics as of Q4 2016.
Based on Occidental Asset Management's 13F filing for Q4 2016, filed 15 May 2019.